EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels

Jéssica Veiga-Matos iD, Ana I Morales iD, Marta Prieto iD, Fernando Remião iD, Renata Silva iD

Molecules · 2023

DOI: 10.3390/molecules28227532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Jéssica Veiga-Matos und 4 weiteren Autor:innen. Beteiligte Einrichtung: UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 405…. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 1, Membrane Transport Proteins. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT—Fundação para a Ciência e a Tecnologia, Research Unit on Applied Molecular Biosciences—UCIBIO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P-glycoprotein (P-gp) is a crucial membrane transporter situated on the cell’s apical surface, being responsible for eliminating xenobiotics and endobiotics. P-gp modulators are compounds that can directly or indirectly affect this protein, leading to changes in its expression and function. These modulators can act as inhibitors, inducers, or activators, potentially causing drug–drug interactions (DDIs). This comprehensive review explores diverse models and techniques used to assess drug-induced P-gp modulation. We cover several approaches, including in silico, in vitro, ex vivo, and in vivo methods, with their respective strengths and limitations. Additionally, we explore the therapeutic implications of DDIs involving P-gp, with a special focus on the renal and intestinal elimination of P-gp substrates. This involves enhancing the removal of toxic substances from proximal tubular epithelial cells into the urine or increasing the transport of compounds from enterocytes into the intestinal lumen, thereby facilitating their excretion in the feces. A better understanding of these interactions, and of the distinct techniques applied for their study, will be of utmost importance for optimizing drug therapy, consequently minimizing drug-induced adverse and toxic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily B, Member 1Membrane Transport ProteinsATP Binding Cassette Transporter, Subfamily BKidneyDrug Interactions

Stichwörter der Autor:innen

P-glycoproteinactivationex vivoin silicoin vitroin vivoinductioninhibitionkidney

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 1Membrane Transport ProteinsATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Toxicology Unit (Universidad de Salamanca), Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.

ORCID-Profile: Jéssica Veiga-Matos, Ana I Morales, Marta Prieto, Fernando Remião, Renata Silva

Förderung

  • Fundação para a Ciência e Tecnologia
  • FCT—Fundação para a Ciência e a Tecnologia
  • Research Unit on Applied Molecular Biosciences—UCIBIO
  • Associate Laboratory Institute for Health and Bioeconomy—i4HB

Zitieren

APA

Veiga-Matos, J., Morales, A. I., Prieto, M., Remião, F., & Silva, R. (2023). Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Molecules. https://doi.org/10.3390/molecules28227532

Vancouver

Veiga-Matos J, Morales AI, Prieto M, Remião F, Silva R. Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Molecules. 2023. doi:10.3390/molecules28227532

BibTeX
@article{VeigaMatos2023,
  author = {Veiga-Matos, Jéssica and Morales, Ana I and Prieto, Marta and Remião, Fernando and Silva, Renata},
  title = {Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28227532}
}
Kostenlos starten →